Skip to main content

Year: 2024

Parenteral Nutrition Market to Surpass Valuation of USD 12,324.1 Million by 2031 | SkyQuest Technology

The global parenteral nutrition market is growing due to rising chronic diseases and gastrointestinal disorders, with continued expansion expected in the coming years. Westford, USA, Dec. 05, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global parenteral nutrition market size will reach a value of USD 12,324.1 Million by 2031, with a CAGR of 7.6% during the forecast period (2024-2031). Shorter hospital stays, a lower risk of infection, the development of technically sophisticated parenteral nutrition (PN) products with barcode assistance, and the growing preference of PN over enteral nutrition in COVID-19 patients are some of the factors driving the market’s growth. According to the ASPEN20 virtual conference, optimizing results for individuals with COVID-19 still entails proper nutrition. This involved overcoming a...

Continue reading

Cool Roof Coatings Market to Witness 7.20% CAGR by 2031 | SkyQuest Technology

Cool Roof Coatings Market size was valued at USD 4.75 Billion in 2023 to reach USD 8.28 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031). Westford, USA, Dec. 05, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that cool roof coatings market size will attain the value of USD 8.28 Billion by 2031, with a CAGR of 7.20% during the forecast period (2024-2031). The cool roof coatings industry has witnessed tremendous growth in recent years and is expected to expand further in the coming years. This growth can be attributed to several factors such as increasing demand for energy efficient solutions, growing environmental concerns and supportive government regulations. One of the major drivers of the market is the increasing emphasis on sustainability and energy efficiency in the construction industry. Cold roof coatings...

Continue reading

GoldHaven Announces Closing of Private Placement and Access to Annual General Meeting Materials During Postal Strike

VANCOUVER, British Columbia, Dec. 05, 2024 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (“GoldHaven” or the “Company“) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce it has closed its previously announced non-brokered private placement of units of the Company (“Units”). The Company issued an aggregate of 9,500,000 Units at a price of $0.05 per Unit for gross proceeds of $475,000, with each Unit comprised of one common share of the Company (a “Common Share”) and one-half of one common share purchase warrant (a “Warrant”, and collectively, the “Private Placement”). Each Warrant is exercisable to acquire one Common Share (each, a “Warrant Share”) at a price of $0.10 per Warrant Share for a period of 24 months from the date of issuance. Certain directors and officers of the Company acquired Units...

Continue reading

Montauk Metals Provides Corporate Update

TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) — Montauk Metals Inc. (TSX-V: MTK) (the “Company” or “Montauk”) announces that the Company received USD$504,000 from the Republic of Colombia as a costs award in conjunction with International Centre for Settlement of Investment Disputes (“ICSID”) Arbitral Tribunal (the “Tribunal”) ruling, as more fully detailed in the Company’s press release dated June 10, 2024. The Company further announces that the Company repaid USD$235,135, inclusive of USD$35,135 of accrued interest, to Omni Bridgeway (Fund 5) Canada Investments Ltd. (“Omni”), constituting the entirety of the funds owed by the Company to Omni pursuant to the loan and option agreement between the parties, as more fully detailed in the Company’s press release dated December 28, 2023. RISK DISCLOSURE STATEMENT: At the present time, the...

Continue reading

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity firm J-Will Partners Co., Ltd. (“J-Will”), through which JKI will acquire Teva-Takeda The agreement is aligned with Teva’s Pivot to Growth strategy to focus its business The expected divestment of Teva-Takeda, Teva’s business venture in Japan, which includes generics products and legacy products, will allow Teva to focus on bringing its innovative medicines to the Japanese marketTEL AVIV, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) — Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that it has entered into an agreement with JKI, established by the fund managed and operated by J-Will, whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva...

Continue reading

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces the study update and interim analysis results from the Company’s COMBAT-ALS Phase 2b/3 clinical trial of MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) will be presented at the 35th International Symposium on ALS/MND held December 6-8, 2024 in Montreal, Canada. The highlights of the presentation, titled, “COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Trial Update and Interim Analysis Results” (Abstract # 302), include:Study Update: As of November 15, 2024, a total of 217 participants have been enrolled and 183 participants were assigned to either MN-166 or placebo group. Pre-defined...

Continue reading

Pieridae Announces 2025 Guidance & Capital Program

Focused on efficiency, processing revenue growth & debt reduction NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES CALGARY, Alberta, Dec. 05, 2024 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) is pleased to provide 2025 guidance including scope of the 2025 capital program along with production and Net Operating Income1 (“NOI”) projections.2025 Guidance Estimates Initial Guidance (Dec-24)Low HighProduction (boe/d) 23,000 25,000NOI ($M) (1)(2)(3) $75,000 $95,000Operating Netback ($/boe) (1)(2)(3) $9.00 $11.00Capital Expenditures ($M) $25,000 $30,000(1) Refer to the “non-GAAP measures” section of the Company’s latest MD&A(2) Assumes average 2025 AECO price of $2.34/GJ and average 2025 WTI price of USD$68.25/bbl(3) Accounts...

Continue reading

Xtract One Announces First Quarter Fiscal 2025 Results

Active Business Development Pipeline Points to Strong Year Ahead TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced fiscal first quarter results for the three months ended October 31, 2024. All information is in Canadian dollars unless otherwise indicated. First Quarter HighlightsQuarterly revenue of $3.6 million for the three months ended October 31, 2024 versus $3.1 million in the prior-year period.Gross margin of 64% for the first quarter of fiscal 2025 versus 67% in the prior year period.Total contract value of new bookings1 was $4.2 million for the three months ending October 31, 2024...

Continue reading

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Fourth Quarter 2024

EXTON, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on January 7, 2025, to shareholders of record on December 19, 2024.   In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisitions, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis the amount of a regular quarterly dividend. INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS – This press release contains forward-looking statements, which are subject to inherent uncertainties which are difficult...

Continue reading

Major Drilling Announces Second Quarter 2025 Results, Building on Robust Net Cash Position

MONCTON, New Brunswick, Dec. 05, 2024 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (“Major Drilling” or the “Company”) (TSX: MDI), a leading provider of specialized drilling services to the mining sector, today reported results for the second quarter of fiscal 2025, ended October 31, 2024.  Quarterly Highlights:Revenue of $189.3 million, in line with the $190.0 million generated in fiscal Q1, but down 8.6% from $207.0 million in the same period last year. Adjusted gross margin(1) of 30.5%, consistent with the 31.0% achieved in the same period last year as the Company remained focused on higher-margin specialized drilling. EBITDA(1) of $38.7 million, down from $43.6 million in the same period last year. Net earnings of $18.2 million (or $0.22 per share), down from $23.7 million (or $0.29 per share) in the same period...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.